Cingulate Inc. Interest Expense on Debt
Cingulate Inc. (CING) reported Interest Expense on Debt of $236.38 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2026-08-13
- Cingulate Inc. interest expense, debt for the quarter ending 2026-06-30 was $236.38K, a 10.60% increase year-over-year.
- Cingulate Inc. interest expense, debt for the quarter ending 2026-03-31 was $348.31K, a 66.12% increase year-over-year.
- Cingulate Inc. interest expense, debt for the quarter ending 2025-06-30 was $213.71K.
- Cingulate Inc. interest expense, debt for the quarter ending 2025-03-31 was $209.67K.
- Cingulate Inc. interest expense, debt for fiscal 2025 was $901.33K, a 3454.96% increase from fiscal 2024.
- Cingulate Inc. interest expense, debt for fiscal 2024 was $25.35K.
- Cingulate Inc. interest expense, debt for fiscal 2021 was $33.41K, a 38.82% decline from fiscal 2020.
- Cingulate Inc. interest expense, debt for fiscal 2020 was $54.60K.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 12 month |
|---|---|---|---|
| 2026-06-30 | $236.38K 10-Q · filed 2026-08-13 | $584.69K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $348.31K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $901.33K 10-K · filed 2026-03-18 | ||
| 2025-06-30 | $213.71K 10-Q · filed 2026-08-13 | $423.38K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $209.67K 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $25.35K 10-K · filed 2026-03-18 | ||
| 2021-12-31 | $33.41K 10-K · filed 2022-03-28 | ||
| 2020-12-31 | $54.60K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |